Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Indazolyl-1,2,4-thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of disease

Indazolyl-1,2,4-thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of disease

US Patent 10556898 · Granted Feb 11, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Alkynyl quinazoline compounds2025
Aryl dihydro-2H benzo[b][1,4]oxazine sulfonamide and related compounds for use a2021
Aryl dihydro-2H benzo[b][1,4]oxazine sulfonamide and related compounds for use a2021
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compo2020
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compo2020
Aryl dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use a2020
Aryl dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use a2020
Adoptive cellular therapy using an agonist of retinoic acid receptor-related orp2020
Adoptive cellular therapy using an agonist of retinoic acid receptor-related orp2020
Tetrahydroquinoline sulfonamide and related compounds for use as agonists of ROR2019
Tetrahydroquinoline sulfonamide and related compounds for use as agonists of ROR2019
Dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as ago2019